Xeris Biopharma Holdings, Inc

XERSNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

173.6M

on 2026-06-30, from 148.2M on 2024-03-31 10-Q ↗

Newest

S-3 of 2025-03-06. Not read yet. S-3 ↗

1 of its filings are not read yet.

Warrants

40K

Warrants of every class as tagged in the XBRL facts on 2025-06-30. 10-Q ↗

Cash

$121.7M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 2 of its filings are not read yet.